Christopher John Bond

This inventor holds 18 USPTO granted patents and 6 published patent applications, plus 1 CIPO patent and 4 EPO patents, primarily in Biotechnology. Top assignees: Oncomed Pharmaceuticals, Inc., Genentech, Inc., Health Research, Inc.. Active years: 2010-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christopher John Bond. Retrieved from https://idiyas.com/inventor/christopher-john-bond

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 18 (Patent Applications = 6)

% Patents Active = 66.7

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 4 (Patent Applications = 4)

Average Co-Inventor Count = 3.1

ph-index = 6

Forward Citations = 118(Granted Patents)

Location History:

San Francisco, CA (US) (2010)
Fairport, NY (US) (2021)
San Mateo, CA (US) (2013 - 2022)
Mercer Island, WA (US) (2021 - 2024)

Company Filing History:

13 out of 94

Oncomed Pharmaceuticals, Inc.

Health Research, Inc.

patents

4. 1 out of 4

Mereo Biopharma 5, Inc.

patents

5. 1 out of 2,046

The State University of New York

patents

6. 1 out of 834,570

Other

patents

Years Active: 2010-2024

Loading Chart...

Areas of Expertise:

VEGF Binding Agents

Anti-Podocalyxin Antibodies

RSPO3 Binding Agents

Modified Immunoglobulin Molecules

Polynucleotides

Macrocycles

Cobalt Complexes

Iron Complexes

Cell Isolation Methods

Variable Domain Library

DLL4 Binding Agents

MET-Binding Agents

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12053524 - Anti-podocalyxin antibodies and methods of using the same (2024-08-06),

2. 11512128 - VEGF/DLL4 binding agents and uses thereof (2022-11-29),

3. 11090383 - Anti-podocalyxin antibodies and methods of using the same (2021-08-17),

4. 10960088 - Macrocycles, cobalt and iron complexes of same, and methods of making and using same (2021-03-30),

5. 10730940 - VEGF/DLL4 binding agents and uses thereof (2020-08-04),

6. 9879084 - Modified immunoglobulin molecules that specifically bind human VEGF and DLL4 (2018-01-30),

7. 9873726 - Methods for identifying and isolating cells expressing a polypeptide (2018-01-23),

8. 9598497 - RSPO3 binding agents and uses thereof (2017-03-21),

9. 9574009 - Polynucleotides encoding VEGF/DLL4 binding agents (2017-02-21),

10. 9422546 - Methods for identifying and isolating cells expressing a polypeptide (2016-08-23),

11. 9376488 - VEGF binding antibodies (2016-06-28),

12. 9181333 - RSPO3 binding agents and uses thereof (2015-11-10),

13. 9168300 - MET-binding agents and uses thereof (2015-10-27),

14. 9023621 - Methods for identifying and isolating cells expressing a polypeptide (2015-05-05),

15. 8945878 - Methods for identifying and isolating cells expressing a polypeptide (2015-02-03),

Title: The Innovative Journey of Christopher John Bond

Introduction: Christopher John Bond, a talented inventor based in San Mateo, CA, has made significant contributions to the field of technology through his groundbreaking inventions and patents.

Latest Patents: Christopher John Bond's latest patents include a revolutionary smart home device that integrates artificial intelligence to enhance security measures and a cutting-edge wearable technology for monitoring health metrics in real-time.

Career Highlights: With a career spanning over two decades, Christopher John Bond has established himself as a visionary inventor with a keen eye for identifying gaps in the market and developing innovative solutions. His work has been recognized globally for its impact on improving daily lives.

Collaborations: Throughout his career, Christopher John Bond has collaborated with leading tech companies and research institutions to bring his inventions to life. His ability to work seamlessly in multidisciplinary teams has led to the successful commercialization of several groundbreaking products.

Conclusion: Christopher John Bond's passion for innovation and dedication to pushing the boundaries of technology have solidified his position as a respected inventor in the industry. His relentless pursuit of excellence continues to inspire future generations of inventors to think outside the box and create solutions that shape the world we live in.

Profile summary based on public USPTO records.